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Introduction: Consumption of n-3 polyunsaturated fatty acids (PUFA) and antioxidant polyphenols is consid-
ered to decline the risk of cardiovascular disease.
Materials and Methods: To provide an explanation for this cardioprotective effect, we performed an interven-
tion study with proatherogenic Apoe−/− mice which were fed during eight weeks with a high fat diet
supplemented with either walnuts (rich in n-3 PUFA and antioxidant compounds), walnut oil (with n-3
PUFA only) or sunﬂower oil as a control (12 mice per group).
Results: Feeding walnuts, but not walnut oil, caused a 55% reduction in atherosclerotic plaque development in
the aortic arch in comparison to the control diet. This was associated with reduced staining of plaques for
CD36, a scavenger receptor expressed by macrophages. Feeding mice with walnuts also lowered plasma
levels of triglycerides, cholesterol and prothrombin with 36%, 23% and 21 %, respectively, compared to control
diet. In addition, accumulation of lipids in the liver was decreased, while plasma antioxidant capacity was in-
creased. On the other hand, feeding mice with walnut oil did not provoke signiﬁcant changes in these param-
eters in comparison to the control diet. Platelet activation and thrombus formation under ﬂow remained
unchanged with either diet.
Conclusions: In Apoe−/−mice on high fat diet, intake of dietary walnut (but not walnut oil) beneﬁcially inﬂu-
ences lipid metabolism and atherosclerotic plaque development, with no more than limited effects on plate-
let and coagulation function.© 2013 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
In today's world, cardiovascular disease, in particular
atherothrombosis is a major cause of morbidity and death [1]. Both
atherosclerosis and atherothrombosis are multifactorial disorders, in
which an altered lipid metabolism, activation of platelets and the coag-
ulation system, and inﬂammatory processes play predominant roles.
The development of atherosclerotic lesions is markedly promoted by
interactions of plasma lipids, platelets and coagulation factors with
the affected arterial vessel wall [2–4]. In addition to lipid-lowering
and antithromboticmedication, there is recurrent interest in theﬁndingtricht University, P.O. Box 616,
537; fax: +31 43 3884159.
ity.nl (M.J.E. Kuijpers).
lsevier OA license.of nutritional components that can reduce atherosclerotic plaque devel-
opment and suppress eventual thrombotic complications.
Epidemiologic studies have shown signiﬁcant associations be-
tween the intake of n-3 polyunsaturated fatty acids (PUFA) or antiox-
idants, as present in ﬁsh oil, and diminished risk of cardiovascular
disease [5–8]. Mice may provide a suitable animal model to study
the dietary effects of ﬁsh oil, as it was found that ﬁsh oil feeding
lowers the plasma levels of lipids and coagulation factors in hyperlip-
idemic mice, such in agreement with an antithrombotic effect of n-3
PUFA [9]. Another rich source of both n-3 PUFA and antioxidant poly-
phenols are walnuts (Juglans regia L.), which contain the highest con-
tent of α-linolenic acid among all edible plants [10–14]. In a limited
number of human studies, health-promoting effects of walnut con-
sumption have been reported [15,16]. Individual papers yet disagree
whether [17] or not [18] walnut intake affects plasma lipid levels
and platelet activation parameters.
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bined presence of n-3 PUFA and antioxidants, has a cardioprotective
effect by interfering with the atherosclerotic process and hemostatic
reactions. To investigate this, we performed an experimental inter-
vention study with proatherogenic Apoe−/− mice, which were fed
Western-type, high fat and cholesterol diets containing whole walnuts
or puriﬁed walnut oil (rich in n-3 PUFA), such in comparison to a high
fat control diet containing puriﬁed sunﬂower oil (rich in n-6 PUFA).
We determined the dietary effect on atherosclerotic plaque develop-
ment as primary endpoint, and compared this with the effects on lipid
metabolism and on platelet and coagulant functions.
Materials and Methods
Materials
Ketamine and xylazine were obtained from Eurovet (Bladel, The
Netherlands). H-Phe-Pro-Arg chloromethyl ketone (PPACK) was from
Calbiochem (La Jolla CA, USA). Murine PAR4 peptide (GYPGKF) was a
gift from Dr. S. Kunapuli, Temple University (Philadelphia PA, USA).
Low molecular weight heparin (fragmin) was from Pfızer (Capelle a/d
IJssel, The Netherlands). Convulxin was puriﬁed to homogeneity from
the crude venom of Crotalus durissus terriﬁcus (Latoxan, Valence,
France) [19]. Recombinant human tissue factor was from Dade Behring
(Marburg, Germany); Horm type I collagen from Nycomed Pharma
(Munich, Germany); ﬂuorescein isothiocyanate (FITC) labeled annexin
A5 from PharmaTarget (Maastricht, The Netherlands). FITC-labeled
anti-CD62 mAb was from Immunotech (Marseille, France); phycoery-
thrin (PE)-labeled anti-mouse JON/A mAb from Emfret Analytics
(Würzburg, Germany); and anti-mouse CD36 mAb from Chemicon
(BillericaMA, USA). Othermaterials were from sources as described be-
fore [9,20]. All other chemicals came from Sigma (St. Louis MO, USA).
Animals and Diets
Power calculation was performed for calculating the required num-
ber of mice/group to determine dietary effects on plaque size. For calcu-
lating group size (N), the equation of L. Sachs was used, evaluating the
difference between two averages. N=2 (zα/2 - zπ)2×(σ/δ)2, wherein is
2(zα/2 - zπ)2=F. For α=0.05 and π=80%, F0.80 is tabeled as 15.7. As a
consequence, N=15.7×(σ/δ)2, in which the standard deviation σ=
0.047, and the relevant measured difference in plaque size δ=
0.060 mm2. This gave a group size N=9.63 (round up 10), which was
corrected for an expected loss of 20%, using the equation N=(a - 0.2a)
N, resulting in a required number per group of 12.
Experimentswere approved by the local Animal Experimental Com-
mittee. Pathogen free Apoe−/− male mice on a C57Bl/6 background
were obtained from Charles River (Maastricht, The Netherlands). Dur-
ing the study, animals were kept individually in transparent macrolon
cages at 20-22 °C (12 h light/dark cycle; 60% relative humidity). The
mice were allowed to drink water ad libitum and were provided with
5 g of indicated diets daily. Intake of food was estimated by daily back
weighing of uneaten food. Body weight was measured weekly.
During two weeks, 36 mice (aged 8 weeks) were fed a standard pu-
riﬁed diet containing 10 energy% (4 weight%) fat from TestDiet
(AIN-93 M, Richmond IN, USA). Apoe−/− mice on a low-fat diet do not
contain atherosclerotic plaques in the aortic arch at an age of 10 weeks
[21]. The animals were then randomly divided into three groups, and
fed during eight weeks a high fat diet (5 g food/day), containing 0.2
weight% cholesterol and 34 energy% (20 weight%) fat (Supplementary
Table 1). Herein, the standard diet was supplemented with: (i) sunﬂow-
er oil rich in n-6 PUFA (high fat control (HFC) group); (ii) walnut oil rich
in n-3 PUFA (WO group); (iii) whole walnuts rich in n-3 PUFA and other
components such as antioxidant polyphenols (WW group). Thus, ani-
mals from the WW group received daily 1.2 g homogenized walnuts
(Juglans regia L.) per 5 g diet, corresponding to an intake of 24 energy%walnut fat. Other macronutrients, i.e. protein, carbohydrate, and ﬁber
were kept equal in all groups on a weight% base (Supplementary
Table 1). Whole walnuts and walnut oil, both from the same batch of
nuts, were obtained from Zade Edible Oil Company (Konya, Turkey),
as was the sunﬂower oil. Diets were stored in aliquots at −80 °C.
Portions were daily thawed before administration.
At the end of the dietary period, mice were deprived from food for
5 h to obtain sober proﬁles of blood lipids. Two mice of the WO group
died preliminary for unknown reasons. All other 34 mice were used
for blood collection and plaque analysis.
Collection of Blood and Tissues
Micewere anesthetized by subcutaneous injection of 0.1 mg/g body
weight ketamine and 0.02 mg/g body weight xylazine, and blood was
drawn from the retro-orbital plexus. From half of the mice (n=5-6
per group), 0.5 ml blood was collected into PPACK (40 μM, ﬁnal con-
centration) plus heparin (5 U/ml) to measure thrombus formation.
Remaining blood and blood from the other mice was drawn into
trisodium citrate (12.9 mM) to prepare platelets and platelet-free plas-
ma [9,20]. The plasma samples were snap-frozen in liquid nitrogen and
stored at −80 °C for later determination of coagulation factors, lipids
and thrombin generation. Sufﬁcient plasma for these measurements
was obtained from 9 mice in each group. All data obtained are
presented in the paper, and no outlier data were removed.
Immediately after bleeding, the animals were sacriﬁced by dia-
phragm puncture, after which aortic arches and livers were dissected
according to standard protocols [9,22]. The organs were isolated from
adherent tissue, and rinsed with ice-cold saline to remove remaining
blood. Aortic arches including the main branch points (brachiocephalic
trunk, left common carotid artery and left subclavian artery), were care-
fully removed from surrounding tissue, and ﬁxed in 1% formaldehyde.
Main parts of the livers were snap-frozen in liquid nitrogen. Two liver
lobes were ﬁxed in 4% formaldehyde. Fixed tissues were embedded
into parafﬁn and sectioned with a rotary microtome and processed, as
described elsewhere [23].
Measurement of Lipids and Cholesterol
Lipids in diets were extracted with chloroform/methanol and
trans-methylated, after which fatty acid proﬁles were analyzed by gas
chromatography [24]. Plasma levels of total cholesterol (Cholesterol
RTU, Biomerieux, France) and triglycerides (Triglyceride/GB GPO-PAP,
Roche Diagnostics, Switzerland) were measured with enzymatic color-
imetric commercial tests [9]. To measure the lipid content in livers,
frozen liver lobes were homogenized in 250 mM sucrose, 2 mM EDTA
and 10 mM Tris (pH 7.45) by shaking for 30 s at 5000 rpm in a closed
tube [25]. Triglycerides in livers were measured, as described above,
and normalized for protein content, as determined with the BCA meth-
od (Pierce, Rockford IL, USA).
Lipoprotein cholesterol distribution in plasma was assessed by fast
protein liquid chromatography [26,27]. Equal volumes of plasma sam-
ples from 10 animals per group were pooled. The lipoproteins were
size-fractionated with a Superose 6PC 3.2/30 column (Amersham
Biosciences, Roosendaal, The Netherlands).
Plasma levels of triglycerides and cholesterol at baseline, in mice
receiving normal chow diet (4 energy% fat, no cholesterol) were
determined at 0.64±0.24 mM and 19.90±3.7 mM, respectively
(mean±sd, n=10).
Coagulation Parameters
Tissue factor-induced thrombin generation was measured in
citrate-anticoagulated platelet-free plasma triggered with tissue fac-
tor (6 pM) and phospholipids (10 μM), according to the automated
thrombogram method adapted for mouse plasma [9,28]. Plasma
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plasmas, as described [9]. Fibrinogen was determined according to the
Claus method [29].
Histology and Immunohistochemistry
Parafﬁn-embedded livers and aortic archeswithmain branch points
were cut into approximately 40 sections, each 4 μm thick, following
routine procedures [22]. Series of 20 sections, representing the central
area with intact morphology of the complete arch, and serial sections
of liver were used for histological analysis. Four representative sections
(16 μmapart) of each aorta and of the liverwere stainedwith hematox-
ylin and eosin. Total plaque area in the aortic sections (2×4 mm) was
determined by averaging identiﬁed atherosclerotic areas in each of
the four sections. CD36 expression in aortic sections was detected by
staining with anti-mouse CD36 mAb (1:100).
Flow Cytometry
Whole blood samples were diluted in Tyrode's Hepes buffer
(5 mM Hepes, 136 mM NaCl, 2.7 mM KCl, 0.42 mM NaH2PO4, 2 mM
MgCl2, 0.1% glucose and 0.1% BSA, pH 7.45), supplemented with
2 mM CaCl2 and 20 U/ml fragmin. Aliquots were activated for
10 min with ADP (40 μM), convulxin (100 ng/ml) or PAR4 peptide
GYPGKF (0.5 mM) without stirring. Activation of platelet integrin
αIIbβ3 and secretion of α-granules was detected with PE-labeled
JON/A mAb (1:20) and FITC-labeled mAb against CD62P (1:40), re-
spectively [20]. Fluorescence was measured with a FACScan ﬂow
cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA). Data were an-
alyzed by WinMDI 2.9 software [30].
Thrombus Formation Under Flow
Glass coverslips, coated with ﬁbrillar type I collagen, were blocked
with Tyrode's Hepes buffer containing 1% BSA, and mounted into a
transparent parallel-plate ﬂow chamber, as described [31,32]. PPACK/
heparin-anticoagulated blood was perfused through the chamber at a
shear rate of 1000 s-1. During perfusion, high-resolution microscopic
images were recorded in real time with a Visitech imaging system
(Sunderland, United Kingdom) equipped with two parallel-placed in-
tensiﬁed, charge-coupled device cameras for recording brightﬁeld
light and epiﬂuorescence. After 4 min, the ﬂow chamber was perfused
with Tyrode's Hepes buffer pH 7.45 supplemented with 1 U/ml heparin
at the same shear rate for 2 min. Exposure of phosphatidylserine was
detected with FITC-labeled annexin A5 (1 μg/ml). Phase-contrast and
ﬂuorescent images were taken from at least 10 microscopic ﬁelds,
which were randomly chosen. Images were analyzed with MetaMorph
software (Molecular Devices, Sunnyvale, CA, USA).
Antioxidant Capacity
Diet sampleswere lyophilized, and extractedwith sodiumphosphate
buffer (aqueous/water soluble antioxidants) or ethanol (organic/ethanol
soluble antioxidants). Extracted diet samples and plasmas were
deproteinizedwith trichloro acetic acid, and their Trolox equivalent an-
tioxidant capacity (TEAC) was determined using an ABTS [2,2’-azinobis
(3-ethylbenzthiazoline-6-sulfonic acid] decolorization assay, as de-
scribed elsewhere [33]. Antioxidant reducing capacity was expressed
as μM Trolox equivalents. Phenolic content in the diet samples was de-
termined using the Folin-Ciocalteu method [34,35].
Statistical Analysis
Results are expressed as mean±SEM. Signiﬁcance of differences
between a diet intervention group (WO or WW group) and the con-
trol group (HFC) was determined with a parametric t test or anon-parametric Mann–Whitney U test, as required, using Prism
(GraphPad Software version 5.00, San Diego CA, USA). Statistical sig-
niﬁcance was set at pb0.05.Results
Dietary Intervention with Walnuts or Walnut Oil
Three groups of 12 Apoe−/− mice were fed with high fat diets
(33–34 energy% fat, 0.2 weight% cholesterol), with compositions as
shown in the Supplementary Table 1. The control (HFC) group re-
ceived a diet enriched in sunﬂower oil with n-6 PUFA (66%). In the
walnut oil (WO) group, the sunﬂower oil was replaced by puriﬁed
walnut oil, resulting in a high content of n-3 PUFA (10%). In the
whole walnut (WW) group, complete walnuts were given, rich in
both n-3 PUFA (13%) and other walnut components. Energy, carbohy-
drate, protein, fat, as well as ﬁber and cholesterol contents were sim-
ilar in all diets. In addition, fractions of saturated fatty acids (9-11%)
were always low. Analysis indicated that the WW diet was ﬁve-fold
enriched in water-soluble antioxidants and had a 50% higher content
of phenolic compounds, compared to the WO an HFC diets (Supple-
mentary Table 1). During the dietary period of 8 weeks, mice of all
groups similarly increased in body weight, starting from 23–24 g
and reaching 36–38 g (Supplementary Fig. 1).Effects of Walnut Diets on Lipid Proﬁles
After the 8 weeks of diet, blood plasma and livers from all mice
were analyzed for lipid content. In the WW group, plasma levels of
triglycerides and total cholesterol were reduced with 36% and 23%,
respectively, in comparison to the HFC group (Fig. 1A, B). In contrast,
plasma triglycerides and cholesterol of the WO group were compara-
ble to the control group. Proﬁles of cholesterol in lipoproteins were
similar after all diets (Fig. 1C), thus pointing to an overall reduction
in cholesterol of most lipoprotein classes (except HDL) in the WW
group. In a separate control group, plasma triglycerides and choles-
terol levels were measured as baseline values at 0.64±0.24 mM
and 19.90±3.7 mM, respectively (mean±sd, n=10). Liver sections
showed the presence of relatively small lipid droplets in only the
WW group in comparison to the HFC group (Fig. 1D). Liver triglycer-
ides were reduced by 30% in the WW group, whereas no signiﬁcant
reduction was observed in the WO group (Fig. 1E).Effect of Walnut Diets on Atherosclerotic Plaque Development
Aortic arches including main branch points from all mice were iso-
lated and sectioned to determine the development of atherosclerotic
plaques in the aortic region. Per arch, four sections were analyzed for
the determination of lesion size and the expression of CD36, as a
marker of atherosclerosis. Remarkably, animals of the WW group
showed a 55% reduction in overall atherosclerotic plaque area, com-
pared to the HFC group (Fig. 2A-C). In contrast, plaque size in animals
of the WO group was similar to the control group. Immunohisto-
chemistry indicated high staining for the scavenger receptor CD36
within plaque areas, at sites where (CD36-expressing) macrophages
were present (Supplementary Fig. 2). Staining of CD36 was about
50% lower in the WW group compared to the HFC group (Fig. 2D).
Again, no difference was observed between the WO and HFC groups.
For all groups together, staining for CD36 correlated signiﬁcantly with
plaque area (R2=0.72, p=0.0013). Together, these data indicated
that dietary supplementation with walnuts, but not with walnut oil,
restrained the formation of CD36-expressing atherosclerotic plaques
in the aortic region of Apoe−/− mice on high fat diet.
Fig. 1. Walnut diet lowers plasma lipids and diminishes lipid accumulation in livers from Apoe−/− mice. Plasma levels of (A) triglycerides and (B) total cholesterol in mice of the
HFC, WO and WW groups. (C) Plasma cholesterol levels in different lipoprotein fractions. (D) Representative parafﬁn sections of mouse livers stained with hematoxylin-eosin. Bars=
100 μm, with magniﬁed images showing fat droplets. (E) Triglyceride levels in mouse livers for all diet groups. Means±S.E.M (n=8); *pb0.05 vs. HFC group; n.s., not signiﬁcant.
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Considering evidence that dietary n-3 PUFA in ﬁsh oil reduce plas-
ma lipids and coagulant activity in hyperlipidemic patients and mice
[8,9], we also measured these parameters in the present study.
Plasma level of prothrombin was reduced by 21% in the WW group
in comparison to the HFC group, but levels of ﬁbrinogen or factor V
were not different (Fig. 3A-C). For all groups together, plasma levelsFig. 2. Whole walnut diet reduces atherosclerotic lesion development in Apoe−/− mice. Pr
8 weeks of HFC, WO or WW diet. (A) Representative HE-stained sections with plaques (bars
tent in aortic arches; data points representing values from individual mice (average of 4 sect
Means±SEM (n=10-12); *pb0.05 vs. HFC group; n.s., not signiﬁcant.of prothrombin and factor V were closely correlated (R2=0.67, p=
0.02). As an overall test of the plasma coagulant activity, thrombin
generation was measured in tissue factor-triggered plasma [36].
Thrombin peak height - i.e. a measure of the maximal rate of throm-
bin generation - was not different between the groups, although it
tended to be lower in the WW group (Fig. 3D).
Plasma samples were furthermore analyzed for Trolox equivalent
antioxidant capacity (TEAC). The higher intake of water-solubleogression of atherosclerotic plaques was analyzed in aortic arches from all mice after
, 1 mm). (B) Magniﬁed areas indicating aortic wall (a) and plaque (p). (C) Plaque con-
ions per aorta). (D) Quantiﬁcation of CD36 staining intensity of identiﬁed plaque areas.
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creased antioxidant capacity in WW plasmas, but not WO plasmas,
when compared to the HFC group (Supplementary Fig. 3).
Effect of Walnut Diets on Platelet Activation and Thrombus Formation
Knowing that in vitro addition of antioxidants can inhibit blood
platelet function [38,39], we determined the effects of the WO and
WW diets on platelet activation markers. Flow cytometry showed that
αIIbβ3 integrin activation (measured with JON/A mAb) and α-granule
secretion (measured with anti-CD62P mAb) were unchanged in re-
sponse to the key agonists ADP, convulxin or PAR4 peptide, when the
WW and WO groups were compared to the HFC group (Fig. 4A, B).
Platelet reactivity was also measured under more physiological condi-
tions, i.e. in whole blood perfused over a collagen surface at arterial
shear rate [30]. In this ex vivo assay, platelets from all diet groups
were similarly active in forming aggregates (Fig. 4C, D). Post-staining
of the platelets with FITC-annexin A5 to probe procoagulant activity
alsowas unchanged in theWWandWOgroups. Accordingly, no dietary
effect ofWWorWO in comparison toHFC, could be detected on platelet
function.
Discussion
In this paper, we investigated the effects of walnuts and walnut oil
on markers of atherothrombosis in Apoe−/− mice, which were given
to the animals as part of a high fat and cholesterol containing diet, in
comparison to a high fat sunﬂower oil diet. We found that only the in-
take of whole walnuts, but not of walnut oil, caused a major reduction
in atherosclerotic plaque formation. This diet effect was accompanied
by a lowering of the triglycerides in blood plasma and the liver, an in-
creased anticoagulant capacity of plasma, and a slight reduction in plas-
ma prothrombin, but not by detectable changes in platelet activation or
coagulation activation. In contrast, the walnut oil diet did not change
these parameters in comparison to the sunﬂower oil diet.
Walnuts are particularly interesting as dietary components, since they
contain both antioxidant polyphenols and n-3 PUFA (mainly α-linolenic
acid), both of which are considered to promote cardiovascular health.
In the present study, we ascertained that the contents of water-solubleFig. 3.Moderate effect of whole walnut diet on coagulation parameters. Plasma samples of m
potential, using the calibrated automated thrombin generation assay. Shown are plasma l
thrombin generation curves. Means±SEM (n=9); *pb0.05, # p=0.05 vs. HFC group; n.s.,antioxidants as well as phenolics were enriched inWWdiet, in compar-
ison to the WO diet, whereas both diets were similarly enriched in n-3
PUFA. Since intake of walnut oil did not mimic the atheroprotective
and lipid-lowering effects of whole walnut intake, it is unlikely that
these changeswere due to the intake of n-3 PUFA alone. In apparent con-
trast, in an earlier studywith APOE2 knock-inmice,we found thatﬁsh oil
intake resulted in lowered plasma lipids and reduced coagulant activity
[9]. However, given the much higher levels of n-3 PUFA in ﬁsh oil (59%
eicosapentaenoic plus docosahexaenoic acids) than in walnut oil (14%
α-linolenic acid), it is conceivable that in the present study the amount
of n-3 PUFA intake was too low for these changes to occur.
The ability of walnuts, but not walnut oil, to greatly restrain athero-
sclerotic plaque progression in comparison to a high fat control diet
with n-6 PUFA is a novel ﬁnding. An earlier, small study pointed to
somewhat increased lipid levels and increased atherosclerosis in
Apoe−/−mice fed with walnut oil [40]. On the other hand, data from a
human intervention study indicated that the regular intake of walnuts
associates with a lowering of plasma triglycerides [41]. Compatible
with the present results, several reports indicate that walnut extracts
in cultured cells reduce the expression of cell adhesion molecules and
lower the release of proinﬂammatory cytokines [42–44].
Interestingly, we measure a reduced expression of CD36 in the
plaque regions of the aortic arch after walnut intake, which is a rele-
vant ﬁnding, given that CD36 is mainly localized on macrophages in
the atherosclerotic lesions [45,46]. It has also been shown that CD36
contributes to the atherosclerotic process, since CD36 deﬁciency in
Apoe−/− mice protects against plaque development [47,48].
Collectively, the data of this mouse study do not point to more
than minor effects of walnut or walnut-oil intake on platelet and co-
agulation activities. After walnut intake, prothrombin in plasma was
moderately lowered, while ﬁbrinogen and factor V levels remained
unaltered. Similarly, human intervention studies do not report on ef-
fects of walnut intake on coagulation parameters [49,50] or platelet
activation [18]. We have to note that smaller numbers of animals
were used for the platelet activation markers and thrombus forma-
tion compared to the plasma markers for cholesterol, triglycerides
and coagulation factors. This may be a limitation of the study.
It is tentative to assume that the atheroprotective effect of walnuts
is a consequence of the simultaneous presence of α-linolenic acid andice from all diet groups were analyzed for coagulation factors and thrombin generation
evels of (A) ﬁbrinogen; (B) prothrombin; (C) factor V; (D) thrombin peak heights of
not signiﬁcant.
Fig. 4. No effect of walnut diets on platelet activation and thrombus formation. Blood from Apoe−/− mice, fed the various diets, was analyzed for platelet function and thrombus
formation. (A, B) Isolated platelets were stimulated with ADP (40 μM), convulxin (CVX, 100 ng/ml) or PAR4 peptide GYPGKF (0.5 mM) for 10 min. (A) Activation of αIIbβ3
(PE-labeled JON/A mAb, 150 μg/ml) and (B) expression of P-selectin (FITC-anti-CD62P mAb, 1:50) were assessed by ﬂow cytometry. (C, D) PPACK/heparin-anticoagulated
whole blood was ﬂowed 4 min over a collagen surface at 1000 s-1. Thrombus formation was determined by analysis of platelet deposition and procoagulant platelet staining
with FITC-labeled annexin A5. (C) Representative phase contrast and ﬂuorescence images (bars, 10 μm). (D) Surface area coverage of thrombi and of ﬂuorescently labeled
procoagulant platelets. Data are means±SEM (HFC and WW n=6, WO n=5); n.s., not signiﬁcant compared to HFC group.
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literature indeed shows high bio-availability of the antioxidants in
walnuts [51], and increased levels of TEAC in plasma after walnut con-
sumption [37]. The antioxidant polyphenolics of walnuts (estimated
16–18 mg/g) appear to be a complex mixture, which has only partly
been characterizedwith asmain constituents, ellagic acid, ellagitannins,
gallic acid and hydrocinnamic acids like chlorogenic acid [52,53]. Likely,
these components contribute to the increased plasma antioxidant ca-
pacity, seen in the present study. However, the precise contribution of
antioxidant polyphenols still needs to be determined.
Taken together, we report a beneﬁcial effect of dietary walnut in-
take on atherosclerotic plaque development and plasma lipids in hy-
perlipidemic Apoe−/− mice, with no more than limited effects on
platelet and coagulation function. Furthermore, we ﬁnd that the
atheroprotective effect of walnut involves other components than
merely n-3 PUFA.
Supplementary data to this article can be found online at http://
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